Tag: Diabetes: Drugs
Glyburide, Metformin Have Similar Effect in Gestational DM
High efficacy rate for both glyburide, metformin; combo of drugs significantly reduces need for insulin
Varying Safety of Add-On Second-Line T2DM Treatments
For patients taking metformin, TZD and DPP-4i linked to lower mortality, cardiovascular risks
ADA: Liraglutide Lowers Risk for Cardiovascular Events in T2DM
Daily, injected medication shows 'encouraging' results in international trial
High-Dose Metformin Linked to Increases in Child Height
Dose-response relationship between metformin use and increases in height in children, teens
FDA Approves Two New Medications for Diabetes
Tresiba and Ryzodeg approved for use in adults with type 1 and 2 diabetes mellitus
Metformin Linked to Lower Risk of Head, Neck Cancer
Diabetes patients treated with the drug less likely to develop oropharyngeal, nasopharyngeal cancers
FDA Warns of Joint Pain Tied to DPP-4 Inhibitors
Agency advises users with such symptoms to contact their doctor
Metformin in Pregnancy Shows No Effect on Infant Birth Weight
However, metformin can help to control women's blood glucose, researchers find
Gastritis Linked to Metformin-Related GI Side Effects in T2DM
With metformin, mean score for gastrointestinal side effects higher for gastritis subjects over four weeks
FDA: Watch for Ketoacidosis With SGLT2 Inhibitors
Class of drugs includes canagliflozin, dapagliflozin, and empagliflozin
